# PRostate Cancer Enhanced Diagnosis by Calibration Technology

> **NCT06607783** · — · NOT_YET_RECRUITING · sponsor: **Gold Standard Phantoms** · enrollment: 66 (estimated)

## Conditions studied

- Prostate Cancers

## Interventions

- **DIAGNOSTIC_TEST:** MRI

## Key facts

- **NCT ID:** NCT06607783
- **Lead sponsor:** Gold Standard Phantoms
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2026-09
- **Final completion:** 2026-12
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2025-08-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06607783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06607783, "PRostate Cancer Enhanced Diagnosis by Calibration Technology". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06607783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*